Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better ...
DaTscan is a radioactive diagnostic agent that works by binding reversibly to the human dopamine transporter (DaT) in the brain. The Food and Drug Administration (FDA) has expanded the approval of ...
(RTTNews) - GE Healthcare (GE) announced on Thursday that DaTscan was approved by FDA for use in patients with suspected Dementia with Lewy Bodies or DLB. DaTscan is a radiopharmaceutical imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results